164 related articles for article (PubMed ID: 23691469)
1. Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report.
Gaur S; Torabi A; O'Neill TJ
Cancer Biol Med; 2012 Jun; 9(2):133-6. PubMed ID: 23691469
[TBL] [Abstract][Full Text] [Related]
2. Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma.
Pallotti MC; Nannini M; Agostinelli C; Leoni S; Scioscio VD; Mandrioli A; Lolli C; Saponara M; Pileri S; Bolondi L; Biasco G; Pantaleo MA
World J Gastroenterol; 2014 Jun; 20(22):7049-54. PubMed ID: 24944501
[TBL] [Abstract][Full Text] [Related]
3. Treatment of pulmonary epithelioid hemangioendothelioma with combination chemotherapy: Report of three cases and review of the literature.
Ye B; Li W; Feng J; Shi JX; Chen Y; Han BH
Oncol Lett; 2013 May; 5(5):1491-1496. PubMed ID: 23759830
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report.
Raphael C; Hudson E; Williams L; Lester JF; Savage PM
J Med Case Rep; 2010 Dec; 4():413. PubMed ID: 21176188
[TBL] [Abstract][Full Text] [Related]
5. VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature.
Telli TA; Okten IN; Tuylu TB; Demircan NC; Arikan R; Alan O; Ercelep O; Ones T; Yildirim AT; Dane F; Yumuk PF
Curr Probl Cancer; 2020 Oct; 44(5):100568. PubMed ID: 32201052
[TBL] [Abstract][Full Text] [Related]
6. Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib.
Sangro B; Iñarrairaegui M; Fernández-Ros N
Rare Tumors; 2012 Apr; 4(2):e34. PubMed ID: 22826791
[TBL] [Abstract][Full Text] [Related]
7. Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.
Rahman HT; Yeh S; Bergstrom CS
J Ocul Pharmacol Ther; 2013 Apr; 29(3):360-2. PubMed ID: 23061416
[TBL] [Abstract][Full Text] [Related]
8. The effect of paclitaxel and nab-paclitaxel in combination with anti-angiogenic therapy in breast cancer cell lines.
Tonissi F; Lattanzio L; Merlano MC; Infante L; Lo Nigro C; Garrone O
Invest New Drugs; 2015 Aug; 33(4):801-9. PubMed ID: 25947567
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up.
Salech F; Valderrama S; Nervi B; Rodriguez JC; Oksenberg D; Koch A; Smok G; Duarte I; Pérez-Ayuso RM; Jarufe N; Martínez J; Soza A; Arrese M; Riquelme A
Ann Hepatol; 2011; 10(1):99-102. PubMed ID: 21301019
[TBL] [Abstract][Full Text] [Related]
10. Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma.
Lau A; Malangone S; Green M; Badari A; Clarke K; Elquza E
Ther Adv Med Oncol; 2015 Jul; 7(4):229-36. PubMed ID: 26136854
[TBL] [Abstract][Full Text] [Related]
11. Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease.
Sumrall A; Fredericks R; Berthold A; Shumaker G
J Neurooncol; 2010 Apr; 97(2):275-7. PubMed ID: 19898746
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma.
Mascarenhas RC; Sanghvi AN; Friedlander L; Geyer SJ; Beasley HS; Van Thiel DH
Oncology; 2004; 67(5-6):471-5. PubMed ID: 15714004
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.
Reynolds C; Barrera D; Jotte R; Spira AI; Weissman C; Boehm KA; Pritchard S; Asmar L
J Thorac Oncol; 2009 Dec; 4(12):1537-43. PubMed ID: 19887966
[TBL] [Abstract][Full Text] [Related]
14. Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).
Rugo HS; Barry WT; Moreno-Aspitia A; Lyss AP; Cirrincione C; Leung E; Mayer EL; Naughton M; Toppmeyer D; Carey LA; Perez EA; Hudis C; Winer EP
J Clin Oncol; 2015 Jul; 33(21):2361-9. PubMed ID: 26056183
[TBL] [Abstract][Full Text] [Related]
15. Multifocal epithelioid hemangioendothelioma: case report of a clinical chamaeleon.
Bölke E; Gripp S; Peiper M; Budach W; Schwarz A; Orth K; Reinecke P; van de Nes JA
Eur J Med Res; 2006 Nov; 11(11):462-6. PubMed ID: 17182357
[TBL] [Abstract][Full Text] [Related]
16. Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options.
Semenisty V; Naroditsky I; Keidar Z; Bar-Sela G
BMC Cancer; 2015 May; 15():402. PubMed ID: 25967676
[TBL] [Abstract][Full Text] [Related]
17. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas.
Agulnik M; Yarber JL; Okuno SH; von Mehren M; Jovanovic BD; Brockstein BE; Evens AM; Benjamin RS
Ann Oncol; 2013 Jan; 24(1):257-63. PubMed ID: 22910841
[TBL] [Abstract][Full Text] [Related]
18. Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib.
Symonds L; Linden H; Gadi V; Korde L; Rodler E; Gralow J; Redman M; Baker K; Wu QV; Jenkins I; Kurland B; Garrison M; Smith J; Anderson J; Van Haelst C; ; Specht J
Clin Breast Cancer; 2019 Apr; 19(2):e283-e296. PubMed ID: 30737173
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.
Palumbo R; Sottotetti F; Trifirò G; Piazza E; Ferzi A; Gambaro A; Spinapolice EG; Pozzi E; Tagliaferri B; Teragni C; Bernardo A
Drug Des Devel Ther; 2015; 9():2189-99. PubMed ID: 25931813
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study.
Minion LE; Chase DM; Farley JH; Willmott LJ; Monk BJ
Gynecol Oncol Res Pract; 2016; 3():4. PubMed ID: 27231575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
